COVID-19 Treatment and Monoclonal Antibodies (MAB)

More Information About COVID-19 Treatments:

Free monoclonal antibody (MAB) treatments are available in Archuleta & La Plata Counties.  The public is directed to consult with a physician for a referral or call your local hospital if seeking monoclonal antibody treatment.

COVID-19 monoclonal antibodies can help prevent severe illness for some people who get infected with COVID-19. The FDA has authorized these neutralizing antibody treatments for emergency use. The treatments are available to people who have tested positive for COVID-19, have mild to moderate symptoms, and who are at high risk of developing severe illness.

More information about monoclonal antibody treatments and eligibility is available on the CDPHE website. Questions about monoclonal antibody treatments should be directed to CDPHE by calling 1-877-COVAXCO (1-877-268-2926). Monoclonal antibody treatments may also be available through existing health care providers in the region. The public is directed to first consult with their physician for a referral if seeking monoclonal antibody treatment from a local hospital.

People at high risk of becoming seriously ill from COVID-19 include:

  • People who are 65 years old or older.
  • People who are obese or overweight. This includes adults with a BMI of 25 or more. It also includes children under the age of 18 years old whose providers determine they meet the criteria.
  • Pregnant people
  • People with certain underlying medical conditions

Paxlovid

  • For treatment of mild-to-moderate COVID-19 in adults and pediatric patients 12 years of age and older weighing at least 40 kilograms or about 88 pounds.
  • For patients who have positive results of direct COVID-19 testing AND who are at high risk for progression to severe COVID-19, including hospitalization or death. Please ask your primary care physician if you should seek Paxlovid in the event you test positive for COVID-19.
  • Available by prescription only and should be initiated as soon as possible after a diagnosis of COVID-19 and within five days of symptom onset.
  • Patients who start Paxlovid and are subsequently admitted to the hospital may finish the prescription at the discretion of their treating provider.
  • Special attention should be given to Paxlovid contraindications which can be found in the FDA EUA “Fact Sheet For Healthcare Providers: Emergency Use Authorization For Paxlovid,” particularly interactions with other medications.
  • Paxlovid is administered as three tablets (two tablets of nirmatrelvir and one tablet of ritonavir) taken together orally twice daily for five days, for a total of 30 tablets.
  • There are pharmacies in both La Plata and Archuleta counties that can offer Paxlovid with a prescription from your physician.  Supplies could be limited, so please ask your physician’s office to check availability before they send in your prescription.

Molnupiravir

  • For the treatment of mild-to-moderate coronavirus disease (COVID-19) in adults aged 18 years or older.
  • For patients who have positive results of direct COVID-19 viral testing, AND who are at high risk for progression to severe COVID-19, including hospitalization or death, AND for whom alternative COVID-19 treatment options authorized by the FDA are not accessible or clinically appropriate. Please ask your primary care physician if you should seek Molnupiravir in the event you test positive for COVID-19.
  • Available by prescription only and should be initiated as soon as possible after diagnosis of COVID-19 and within five days of symptom onset.
  • Molnupiravir is not authorized for use in patients younger than 18 years of age because Molnupiravir may affect bone and cartilage growth.
  • It is not authorized for the pre-exposure or post-exposure prevention of COVID-19 or for initiation of treatment in patients hospitalized due to COVID-19 because benefit of treatment has not been observed in people when treatment started after hospitalization due to COVID-19.
  • Special attention should be given to Molnupiravir in special populations (such as pregnant individuals or people of childbearing age) which can be found in the FDA’s Fact Sheet For Healthcare Providers: Emergency Use Authorization For Molnupiravir. Molnlupiravir is not recommended in pregnancy.
  • There are pharmacies in both La Plata and Archuleta counties that can offer Molnupiravir with a prescription from your physician. Supplies could be limited, so please ask your physician’s office to check availability before they send in your prescription.

Telehealth

  • If you test positive or think you have COVID-19, you may be able to use telehealth to access treatment options faster. COVID-19 treatment works best if you take it within a few days of feeling sick or testing positive.
  • Telehealth means connecting with a doctor over the phone or through a video call. Using telehealth, a doctor can assess you and, if appropriate, give you a treatment plan that meets your needs.
  • If you have a health care provider, ask them if telehealth is an option for learning more about COVID-19 treatment. If you don’t have a provider or your provider doesn’t offer telehealth, you may be able to access telehealth directly. Learn more about telehealth providers that can prescribe COVID-19 treatment in Colorado.